Skip to content
10-Q

Quarterly Report

MYOKARDIA, INC.

0001564590-20-022014

← back to feed
Filed
May 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 1, 2020 46.68M sh
Capex Q1 2020 · Mar 31, 2020 $12.63M
Capex Q1 2020 · Mar 31, 2019 $813K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$59.9M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$38.05M
Short Term Investments Q1 2020 · Mar 31, 2020 $218.81M
Short Term Investments Q1 2020 · Dec 31, 2019 $314.69M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $131.2M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $101.44M
Stockholders Equity Q1 2020 · Mar 31, 2020 $349.1M
Stockholders Equity Q1 2020 · Dec 31, 2019 $406.27M
Stockholders Equity Q1 2020 · Mar 31, 2019 $611.94M
Stockholders Equity Q1 2020 · Dec 31, 2018 $370.57M
Current Liabilities Q1 2020 · Mar 31, 2020 $45.66M
Current Liabilities Q1 2020 · Dec 31, 2019 $47.91M
Total Liabilities Q1 2020 · Mar 31, 2020 $92.23M
Total Liabilities Q1 2020 · Dec 31, 2019 $49.82M
Current Assets Q1 2020 · Mar 31, 2020 $357.5M
Current Assets Q1 2020 · Dec 31, 2019 $423.84M
Total Assets Q1 2020 · Mar 31, 2020 $441.33M
Total Assets Q1 2020 · Dec 31, 2019 $456.09M
Sga Expense Q1 2020 · Mar 31, 2020 $19.9M
Sga Expense Q1 2020 · Mar 31, 2019 $13.55M
Rd Expense Q1 2020 · Mar 31, 2020 $51.88M
Rd Expense Q1 2020 · Mar 31, 2019 $26.19M
Net Income Q1 2020 · Mar 31, 2020 −$69.87M
Net Income Q1 2020 · Mar 31, 2019 −$37.47M
Operating Income Q1 2020 · Mar 31, 2020 −$71.78M
Operating Income Q1 2020 · Mar 31, 2019 −$39.74M